Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)

Joseph Tintelnot; Alexander Stein; Salah-Eddin Al-Batran; Thomas Ettrich; Thorsten Goetze; Barbara Gruen; Georg Martin Haag; Vera Heuer; Ralf-Dieter Hofheinz; Nils Homann; Tobias Sebastian Broering; Mariana Santos Cruz; Annika Kurreck; Sylvie Lorenzen; Nicolas Moosmann; Christian Mueller; Markus Schuler; Gabriele Siegler; Mascha Binder; Eray Goekkurt

doi:10.3389/FONC.2023.1272175

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)

Joseph Tintelnot
, Alexander Stein
, Salah-Eddin Al-Batran
, Thomas Ettrich
, Thorsten Goetze
, Barbara Gruen
, Georg Martin Haag
, Vera Heuer
, Ralf-Dieter Hofheinz
, Nils Homann
, Tobias Sebastian Broering
, Mariana Santos Cruz
, Annika Kurreck
, Sylvie Lorenzen
, Nicolas Moosmann
, Christian Mueller
, Markus Schuler
, Gabriele Siegler
, Mascha Binder
, Eray Goekkurt

Universitätsklinik für Innere Medizin 5 - Onkologie und Hämatologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

5 Quellenangaben (Web of Science)

Originalsprache	undefiniert/unbekannt
Fachzeitschrift	FRONTIERS IN ONCOLOGY
DOIs	https://doi.org/10.3389/FONC.2023.1272175
Publikationsstatus	Veröffentlicht - 2023

Zugriff auf Dokument

10.3389/FONC.2023.1272175

Andere Dateien und Links

https://publons.com/wos-op/publon/65643952/

Dieses zitieren

Tintelnot, J., Stein, A., Al-Batran, S.-E., Ettrich, T., Goetze, T., Gruen, B., Haag, G. M., Heuer, V., Hofheinz, R.-D., Homann, N., Broering, T. S., Cruz, M. S., Kurreck, A., Lorenzen, S., Moosmann, N., Mueller, C., Schuler, M., Siegler, G., Binder, M., & Goekkurt, E. (2023). Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321). FRONTIERS IN ONCOLOGY. https://doi.org/10.3389/FONC.2023.1272175

@article{c6a3576330404227a57d1559c092cb5e,

title = "Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)",

author = "Joseph Tintelnot and Alexander Stein and Salah-Eddin Al-Batran and Thomas Ettrich and Thorsten Goetze and Barbara Gruen and Haag, \{Georg Martin\} and Vera Heuer and Ralf-Dieter Hofheinz and Nils Homann and Broering, \{Tobias Sebastian\} and Cruz, \{Mariana Santos\} and Annika Kurreck and Sylvie Lorenzen and Nicolas Moosmann and Christian Mueller and Markus Schuler and Gabriele Siegler and Mascha Binder and Eray Goekkurt",

year = "2023",

doi = "10.3389/FONC.2023.1272175",

language = "Undefined/Unknown",

journal = "FRONTIERS IN ONCOLOGY",

issn = "2234-943X",

publisher = "Frontiers Media Sa",

}

Tintelnot, J, Stein, A, Al-Batran, S-E, Ettrich, T, Goetze, T, Gruen, B, Haag, GM, Heuer, V, Hofheinz, R-D, Homann, N, Broering, TS, Cruz, MS, Kurreck, A, Lorenzen, S, Moosmann, N, Mueller, C, Schuler, M, Siegler, G, Binder, M & Goekkurt, E 2023, 'Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)', FRONTIERS IN ONCOLOGY. https://doi.org/10.3389/FONC.2023.1272175

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321). / Tintelnot, Joseph; Stein, Alexander; Al-Batran, Salah-Eddin et al.
in: FRONTIERS IN ONCOLOGY, 2023.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)

AU - Tintelnot, Joseph

AU - Stein, Alexander

AU - Al-Batran, Salah-Eddin

AU - Ettrich, Thomas

AU - Goetze, Thorsten

AU - Gruen, Barbara

AU - Haag, Georg Martin

AU - Heuer, Vera

AU - Hofheinz, Ralf-Dieter

AU - Homann, Nils

AU - Broering, Tobias Sebastian

AU - Cruz, Mariana Santos

AU - Kurreck, Annika

AU - Lorenzen, Sylvie

AU - Moosmann, Nicolas

AU - Mueller, Christian

AU - Schuler, Markus

AU - Siegler, Gabriele

AU - Binder, Mascha

AU - Goekkurt, Eray

PY - 2023

Y1 - 2023

UR - https://publons.com/wos-op/publon/65643952/

U2 - 10.3389/FONC.2023.1272175

DO - 10.3389/FONC.2023.1272175

M3 - Original Article

SN - 2234-943X

JO - FRONTIERS IN ONCOLOGY

JF - FRONTIERS IN ONCOLOGY

ER -